Gary Donovitz, MD, FACOG, is leading a healthcare revolution that focuses on optimizing and balancing bioidentical hormones for aging healthier and living happier by supporting heart, bone, brain, and sexual health, improved energy, and clarity, and happiness for men and women of all ages.*
After practicing as a Board-Certified OB/GYN for 30 years, Dr. Donovitz is now an internationally recognized leader, speaker, educator, and advocate of hormone optimization. He is the Founder of Biote, a leading innovator in subcutaneous hormone pellet therapy. He has personally performed more than 50,000 pellet insertions.
The Biote state-of-the-art training facility hosts physicians, healthcare providers, and medical staff members monthly during the Biote Method learning and certification process. Over 4,700 providers in more than 2,800 clinics nationwide have successfully completed his rigorous curriculum and clinical training program. Collectively, these providers have performed more than 2.5 million pellet insertions to date.
His commitment to constantly raise the bar for healthcare extends beyond hormone therapy, as Dr. Donovitz has been at the forefront of developments in robotic surgery and has trained physicians across the country on how to perform operations using these advances in technology.
Dr. Donovitz received the Isadore Dyer award for best teaching resident while studying at Tulane University in New Orleans, Louisiana. He is a fellow of the American College of Obstetrics and Gynecology, a fellow of the Royal Society of Medicine, the Chairman of the International Consensus Committee on Testosterone Use in Women, and is the Founder of the Institute for Hormonal Balance.
After monitoring outcomes for over 850,000 men and women who have undergone the Biote Method of hormone optimization, results continue to exceed expectations, with more than 96% of patients satisfied with their care.
Chief Executive Officer
Terry S. Weber leads the Biote team in advancing responsible access to scientifically-based, life-enhancing health therapies. Under her stewardship, Biote is accelerating and scaling its work as a collaborative clinical educator and patient advocate in an underserved market that’s been long overlooked by legacy life sciences companies, cementing Biote’s status as the leader in individualized hormone optimization.
As a Founding Board Member of the nonprofit PreventiveMedicine.org, Terry is convening stakeholders dedicated to building respectful dialogue around the integration of wellness expertise and clinical science to provide patients a more comprehensive continuum of patient options for hormone-related conditions, including menopause, diabetes, and others.*
Forging and encouraging exponentially productive disruption is a through line in Terry’s career of executive leadership. As the former CEO of Amen Clinics and brainMD, Terry forged a path to leverage innovative clinical practices, establishing an exceptional roster of physicians, professional managers, and clinic directors and pushing her teams to change the way psychiatry is practiced to the benefit of patients.
Terry now serves on the board of the International Women’s Forum. She has also advised and supported the victims of investment fraud at Investor Advocates and coordinated vocational training for immigrants and single parents at American Workshops.
Terry is a graduate of the New College of Florida and Purdue University. Connect with her on LinkedIn here or reach out to her within the ForbesWomen Forum.
Marc Beer brings more than 25 years of development and commercialization experience in biotechnology, pharmaceutical, device, and diagnostics and has served as CEO of Aegerion Pharmaceuticals, Inc. and ViaCell and as a member of the Erytech Pharma Board of Directors.
A member of the Miami University Business Advisory Council, Mark previously served as a member of the Notre Dame Research and Commercialization Advisory Committee and Notre Dame Graduate Studies Research and Advisory Council.
Marc has led several companies through significant capital raises and public offerings, including Renovia, LumeNXT Inc., Origami Surgical, Liftique, and Minerva Neurosciences Inc. His extensive experience as a Founder, CEO, and Chairman in numerous health-related companies makes him an ideal contributor to support Biote’s growth initiatives.
Chief Financial Officer
Robb Gibbins, Chief Financial Officer, oversees the financial, accounting and budgeting operations at Biote. Robb is a Certified Public Accountant and Chartered Financial Analyst and brings over 25 years of experience as a senior financial executive leading the financial operations of middle-market companies.
His expertise includes financial and accounting process improvement, streamlining financial reporting, creation and implementation of budgeting and forecasting processes, M&A execution, treasury management optimization, and hands-on experience with manufacturing operations and consumer products.
Robb has completed several mergers and acquisitions as well as successful private equity transactions during his career, making him a valuable contributor in supporting growth initiatives for Biote.
Jonathan Sackner-Bernstein, MD
Chief Medical Officer
Dr. Jonathan Sackner-Bernstein is an American physician who has published more than 80 scientific articles. His research has ranged from cardiac care to the efficacy of drugs. Following a career as an academic cardiologist and serving a senior role at The U.S. Food and Drug Administration (FDA), he led operational, regulatory, and development for numerous companies.
At the FDA, Dr. Sackner-Bernstein implemented safety and innovation programs, launched the FDA’s Entrepreneurs-in-Residence program, and led a team to prepare the FDA for a new generation of connected, innovative medical devices. Further, Dr. Sackner-Bernstein served in leadership roles within the Office of the Commissioner and between Federal agencies.
Dr. Sackner-Bernstein served as Chief Medical Officer and VP, Clinical and Regulatory Affairs for Zidan Medical and Chief Medical Officer and Executive Vice President of Clinical and Regulatory Affairs at ROX Medical, where he identified a patent-pending novel candidate drug therapy for Parkinson’s disease. As a consultant to DARPA, Dr. Sackner-Bernstein focused on neuro-technologies and big data to support the launch of the Biological Technologies Office.
Dr. Sackner-Bernstein’s clinical research experience ranges from First-in-Human to international trials, as a clinical investigator and in trial leadership. As an academic, Dr. Sackner-Bernstein held academic appointments in cardiology at Columbia University and North Shore LIJ Health System-Northwell following training at Mount Sinai Medical Center in New York.
Chief Information Officer
Joe Butler is the Chief Information Officer & Vice President of Support Services at Biote. As CIO, he leads strategic IT initiatives that align with Biote’s long-term goals. He works closely with the entire Biote community to deliver innovative technologies and service programs that benefit Biote Providers and their patients.
He comes to Biote with more than 25 years of experience in Systems Development, Supply Chain Operations Management, and Business Process Re-Engineering. Before joining the Biote executive team, Joe served as VP, Head of Global Infrastructure Programs at DPDHL IT Services, where he oversaw all IT Services and infrastructure-related change programs while managing more than 60 FTE and contract-based PMs. He also served as Global Head of Integration Platforms for DHL Supply Chain.
Joe received his Bachelor of Arts from Arizona State University and his Master of Business Administration Technology Management from the University of Phoenix. He holds several certifications, including PMP, PRINCE2, APICS, and is a Six Sigma Green Belt. Joe is also fluent in Spanish, Italian, and Filipino.
Vice President Of Sales
Cary Paulette is Vice President of Sales for Biote, bringing more than 20 years of medical device and technology experience. Cary began his medical device career at Boston Scientific and has held executive and leadership roles in companies serving a variety of markets, including women’s health, venous insufficiency, and urology.
Before joining the Biote team, Cary served as Executive Vice President at Thermi, and Senior Vice President of Sales at Ellman International, Cynosure, Joerns Healthcare, and Telligent Systems. He is an entrepreneurial, profit-oriented sales leader with a demonstrated track record of increasing revenue, market share, and earnings to help pave the way for Biote’s success.
Chief Digital Officer and Head of Marketing
Kevin Key is the Chief Digital Officer and Head of Marketing for Biote. Kevin brings over 24 years in the marketing and advertising industry leading and managing high performing teams for world-class brands in automotive, CPG, financial services, travel, hospitality, dining, retail, pharmaceutical, and telecommunications.
Prior to joining Biote, Kevin was Vice President of Digital Marketing for Mr. Cooper/Nationstar Mortgage where he led the digital marketing for the 3rd largest home servicer in the country with $21B in loans originated. Prior to Nationstar, Kevin was AVP Digital Marketing for General Motors where he led the digital marketing for the financial division. Kevin also spent 18 years in leadership positions at marketing agencies managing brands such as P&G, General Motors, Southwest Airlines, Dominos, Eli Lilly and GlaxoSmithKline.
Kevin is now leveraging his deep experience and passion for business strategy, insights, creative, data, analytics and technology to lead Biote through its growth and digital transformation.
General Counsel & Business Development
As Biote’s General Counsel, Marybeth Conlon brings more than 17 years of professional law experience and expertise. Marybeth Conlon is founder of The Conlon Law Firm and began her legal career at Travis & Thompson, P.C. in Dallas where she was named partner at Travis, Calhoun & Conlon, P.C. She is a member of the Business Law, Construction Law, Labor and Employment Law, Litigation, and Real Estate, Probate, and Trust Law Sections of the Texas State Bar. Marybeth is also a member of the State Bar of Texas, Dallas Bar Association, Dallas Chapter of the Federal Bar Association, Texas Young Lawyers Association, and serves as a Fellow of the Dallas Bar Association Foundation.
In 2011, Marybeth was selected by the readers of Addison Magazine as one of twelve nominees for the magazine’s Top Female Executive award. Since 2012, she has been selected for inclusion in Thomson Reuters’ Texas Super Lawyers–Rising Stars Edition and in 2021, was selected for inclusion in Thomson Reuters’ Texas Super Lawyers.
Marybeth has served two terms as the President of the Circle of Friends Board for New Friends New Life, and is a member of the Dallas Museum of Art League, Stewpot Alliance, Equest Women’s Auxiliary, Genesis Alliance, Women’s Auxiliary to Children’s Medical Center, the Partnership / Community Partners of Dallas Women’s Auxiliary, Dallas Opera Women’s Board, and The Crystal Charity Ball and is an active member of the Owners Advisory Council.
Director of Talent & Human Resources
Jennifer Schimmel joined Biote in 2019 as the Director, Human Resources & Talent with U.S. & Caribbean responsibility for human resources, talent development, and company culture initiatives. Jennifer has more than 20 years of progressive HR experience with a concentrated focus on developing strategies and optimal processes for high-growth companies.
Prior to joining Biote, Jennifer was the Director of HR at DeliverCareRx Pharmacy, a national home delivery pharmacy servicing those with chronic conditions as well those in hospice care through Optum. Preceding DeliverCareRx, she was the Director of HR & Administration at CAC Group, a marketing analytics firm with U.S. and Canadian clients such as Constellation Energy, Morton’s The Steakhouse, and Blackberry.
Jennifer holds a Bachelor degree in Business Administration from Roosevelt University with additional certifications in human resources related competencies. Personal interests include efforts to reduce child trafficking and child hunger as well as exploring new cultures.
Sr. Director, Supply Chain & Facility Management
Ed has over twenty-six years manufacturing and supply chain management experience. He has worked with companies ranging from startups to Fortune 500 organizations in a variety of industries including: Medical Device, Pharmaceuticals, Food & Beverage, Food Service, Automotive, Industrial Equipment, Electric Power Generation & Distribution, Health Care, Railroad, Trucking and Transportation, Construction Material and Retail. He has a track record of success in streamlining operations, maximizing productivity and leading organizations to improved profitability. Ed is Certified in Production and Inventory Management (CPIM) by The Association for Operations Management (APICS).
Prior to joining Biote, Ed ran the Supply Chain Strategy group at Dr. Pepper Snapple Group, where he had responsibility for optimizing the production and distribution planning for a network of 19 manufacturing plants, 4 regional distribution centers and 142 local distributions centers. Ed was also Director of Supply chain for Galderma, a dermatology focused pharmaceutical company where his responsibilities included inventory management, warehousing, distribution, transportation, and management of imports.
Ed directs the overall supply chain operations, including purchasing and inventory, selection of vendors, and distribution of finished goods. He and his team ensure that customers are always able to obtain the inventory they need to run a successful operation.